Investing

AbbVie : ABBV

ABBV

Stock Data

$232.70

$7.53 (3.34%)

Asset Type

Common Stock

Exchange

NYSE

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DRUG MANUFACTURERS - GENERAL

Abbvie Inc. is a global pharmaceutical company that focuses on discovering, developing, manufacturing, and selling a wide range of treatments. Its portfolio includes therapies for autoimmune diseases, various cancers, eye diseases, neurological disorders, and more. Notable products include Humira for autoimmune conditions, Skyrizi and Rinvoq for skin and joint diseases, and Imbruvica for blood cancers. AbbVie also offers products in aesthetics, women's health, and eye care. Founded in 2012 and based in North Chicago, Illinois, AbbVie collaborates with several biotech firms to advance its research in oncology and immunology.

All AbbVie Articles

530 Articles

Lee Jackson | Nov 4, 2025

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More

Pre-Market Futures: The S&P 500 and NASDAQ futures are trading down over 1% on Tuesday, following Palantir’s 6.9% decline despite…

Lee Jackson | Oct 17, 2025

5 Safe Forever Dividend Stocks To Buy Now and Hold For Life

At 24/7 Wall St., we have closely followed dividend-paying stocks for over 15 years. With a growing audience of savvy…

Rich Duprey | Oct 14, 2025

I have invested in dividends for 11 years—These income machines pay me every quarter without a hitch

Over the past 11 years, I’ve built a portfolio centered on steady dividend payers, stocks that deliver reliable income quarter…

John Seetoo | Oct 4, 2025

Top Dividend Stocks Poised for Explosive Growth in 2026 (ABBV, GD, RGR)

Geopolitical events, judicial rulings, new law legislation, and policy changes are all circumstances occurring on domestic and international stages that…

Rich Duprey | Oct 1, 2025

100% Pharmaceutical Tariffs Are Here. Time to Buy These 3 Drugmakers

Starting today, the U.S. imposed 100% tariffs on imports of branded or patented pharmaceutical products that President Trump announced last…

Omor Ibne Ehsan | Sep 28, 2025

Build Your Lifetime Income Stream: 5 Dividend ETFs Worth Owning

If you are looking for a source of income that outlives you, look into dividend ETFs that are time-tested over…

Rich Duprey | Sep 24, 2025

Unlock Endless Income: SCHD’s Latest Dividend Hike Makes It a Must-Buy ETF

Why Dividend Growth Investing Builds Lasting Wealth In the world of investing, few strategies match the quiet power of dividend…

John Seetoo | Aug 10, 2025

4 Overlooked Dividend Aristocrat Stocks with Up To 60%+ Growth Potential

With all of the attention focused on the Magnificent 7 tech stocks, AI, and biotech stocks that are all high…

Omor Ibne Ehsan | Aug 5, 2025

Jim Cramer Says To Buy These 3 Dividend Stocks ASAP

Jim Cramer may not always have the best calls, but he’s not a bad guru to look to if you…

Lee Jackson | Jul 30, 2025

4 Safe High-Yielding Dividend Aristocrats Are Our Top Picks in a Dangerous Market

These four Dividend Aristocrats are Buy-rated sector leaders with yields above 3%. Passive income investors can buy and hold them…

Lee Jackson | Jul 28, 2025

4 High-Yield Blue-Chip Pharmaceutical Giants Offer Huge Total Return Potential

Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.

Vandita Jadeja | Jul 16, 2025

These 4 Schwab ETFs Are Built for Retirement Stability

If you’re someone who doesn’t like to research individual stocks to generate long-term returns, exchange-traded funds can be your ideal…

Chris MacDonald | Jul 12, 2025

3 No-Brainer Dividend Stocks to Buy In July

There’s really no such thing as a “no brainer” stock pick. I’d say that some opportunities are more compelling than…

Vandita Jadeja | Jul 11, 2025

2 High-Yield ETFs That Are Crushing the S&P 500 This Year

Exchange-traded funds have become a popular investment option for investors seeking to establish a passive income strategy. ETFs have low…

Omor Ibne Ehsan | Jun 26, 2025

2 BlackRock ETFs For Passive Income In Retirement

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through…